11/28
01:15 pm
gkos
Glaukos (GKOS) Up 20% Since Last Earnings Report: Can It Continue? [Yahoo! Finance]
Neutral
Report
Glaukos (GKOS) Up 20% Since Last Earnings Report: Can It Continue? [Yahoo! Finance]
11/11
01:23 pm
gkos
Glaukos Corporation (GKOS) Presents at UBS Global Healthcare Conference 2025 Transcript [Seeking Alpha]
Low
Report
Glaukos Corporation (GKOS) Presents at UBS Global Healthcare Conference 2025 Transcript [Seeking Alpha]
11/10
11:06 am
gkos
Glaukos (NYSE:GKOS) had its "buy" rating reaffirmed by analysts at UBS Group AG.
Low
Report
Glaukos (NYSE:GKOS) had its "buy" rating reaffirmed by analysts at UBS Group AG.
11/9
01:35 pm
gkos
Should Glaukos' Improved Results and Raised Outlook Prompt a Closer Look From GKOS Investors? [Yahoo! Finance]
Medium
Report
Should Glaukos' Improved Results and Raised Outlook Prompt a Closer Look From GKOS Investors? [Yahoo! Finance]
11/3
07:00 am
gkos
Glaukos Announces Participation in Upcoming Investor Conferences
Low
Report
Glaukos Announces Participation in Upcoming Investor Conferences
10/31
08:08 pm
gkos
Glaukos (GKOS): Losses Deepen, But Revenue Forecasts Challenge Bearish Sentiment [Yahoo! Finance]
Low
Report
Glaukos (GKOS): Losses Deepen, But Revenue Forecasts Challenge Bearish Sentiment [Yahoo! Finance]
10/30
06:43 pm
gkos
Glaukos (GKOS) Q3 2025 Earnings Call Transcript [Yahoo! Finance]
Low
Report
Glaukos (GKOS) Q3 2025 Earnings Call Transcript [Yahoo! Finance]
10/30
05:17 pm
gkos
Glaukos (NYSE:GKOS) had its price target raised by analysts at JPMorgan Chase & Co. from $110.00 to $120.00. They now have an "overweight" rating on the stock.
Low
Report
Glaukos (NYSE:GKOS) had its price target raised by analysts at JPMorgan Chase & Co. from $110.00 to $120.00. They now have an "overweight" rating on the stock.
10/30
12:03 pm
gkos
Glaukos (NYSE:GKOS) was given a new $120.00 price target on by analysts at Truist Financial Corporation.
Medium
Report
Glaukos (NYSE:GKOS) was given a new $120.00 price target on by analysts at Truist Financial Corporation.
10/30
10:07 am
gkos
Glaukos (NYSE:GKOS) had its "buy" rating reaffirmed by analysts at Citigroup Inc..
High
Report
Glaukos (NYSE:GKOS) had its "buy" rating reaffirmed by analysts at Citigroup Inc..
10/30
09:12 am
gkos
Glaukos (NYSE:GKOS) was given a new $122.00 price target on by analysts at Wells Fargo & Company.
Medium
Report
Glaukos (NYSE:GKOS) was given a new $122.00 price target on by analysts at Wells Fargo & Company.
10/30
08:09 am
gkos
Glaukos (NYSE:GKOS) had its price target raised by analysts at BTIG Research from $104.00 to $116.00. They now have a "buy" rating on the stock.
Medium
Report
Glaukos (NYSE:GKOS) had its price target raised by analysts at BTIG Research from $104.00 to $116.00. They now have a "buy" rating on the stock.
10/30
08:09 am
gkos
Glaukos (NYSE:GKOS) had its price target raised by analysts at Needham & Company LLC from $115.00 to $117.00. They now have a "buy" rating on the stock.
Medium
Report
Glaukos (NYSE:GKOS) had its price target raised by analysts at Needham & Company LLC from $115.00 to $117.00. They now have a "buy" rating on the stock.
10/29
04:05 pm
gkos
Glaukos Announces Third Quarter 2025 Financial Results
High
Report
Glaukos Announces Third Quarter 2025 Financial Results
10/27
01:01 pm
gkos
Glaukos (NYSE:GKOS) was given a new $115.00 price target on by analysts at Stifel Nicolaus.
Low
Report
Glaukos (NYSE:GKOS) was given a new $115.00 price target on by analysts at Stifel Nicolaus.
10/26
09:26 am
gkos
Can Glaukos' (GKOS) Latest FDA Approval Reinforce Its Corneal Therapy Leadership? [Yahoo! Finance]
Low
Report
Can Glaukos' (GKOS) Latest FDA Approval Reinforce Its Corneal Therapy Leadership? [Yahoo! Finance]
10/20
08:48 am
gkos
Glaukos (NYSE:GKOS) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $104.00 price target on the stock.
High
Report
Glaukos (NYSE:GKOS) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $104.00 price target on the stock.
10/20
07:00 am
gkos
Glaukos Announces FDA Approval of Epioxa™
Medium
Report
Glaukos Announces FDA Approval of Epioxa™
10/14
07:07 am
gkos
Glaukos Innovation to be Highlighted at the 2025 American Academy of Ophthalmology Annual Meeting [Yahoo! Finance]
Low
Report
Glaukos Innovation to be Highlighted at the 2025 American Academy of Ophthalmology Annual Meeting [Yahoo! Finance]
10/14
07:00 am
gkos
Glaukos Innovation to be Highlighted at the 2025 American Academy of Ophthalmology Annual Meeting
Low
Report
Glaukos Innovation to be Highlighted at the 2025 American Academy of Ophthalmology Annual Meeting
10/13
08:20 am
gkos
Glaukos (NYSE:GKOS) had its price target lowered by analysts at BTIG Research from $118.00 to $104.00. They now have a "buy" rating on the stock.
Low
Report
Glaukos (NYSE:GKOS) had its price target lowered by analysts at BTIG Research from $118.00 to $104.00. They now have a "buy" rating on the stock.
10/8
07:00 am
gkos
Glaukos to Release Third Quarter 2025 Financial Results after Market Close on October 29
Medium
Report
Glaukos to Release Third Quarter 2025 Financial Results after Market Close on October 29
10/7
01:29 pm
gkos
Glaukos (NYSE:GKOS) had its price target lowered by analysts at Citigroup Inc. from $140.00 to $110.00. They now have a "buy" rating on the stock.
Low
Report
Glaukos (NYSE:GKOS) had its price target lowered by analysts at Citigroup Inc. from $140.00 to $110.00. They now have a "buy" rating on the stock.
10/3
06:38 am
gkos
Glaukos (NYSE:GKOS) was upgraded by analysts at The Goldman Sachs Group, Inc. to a "strong-buy" rating.
Low
Report
Glaukos (NYSE:GKOS) was upgraded by analysts at The Goldman Sachs Group, Inc. to a "strong-buy" rating.
10/2
01:40 am
gkos
Nicox's NCX 470 Demonstrates Sustained Efficacy through 12 Months in Denali Clinical Trial with no new Safety Observations [Yahoo! Finance]
Low
Report
Nicox's NCX 470 Demonstrates Sustained Efficacy through 12 Months in Denali Clinical Trial with no new Safety Observations [Yahoo! Finance]